Vol 25, No 6 (2018)
Original articles — Interventional cardiology
Published online: 2017-07-14

open access

Page views 3148
Article views/downloads 1027
Get Citation

Connect on Social Media

Connect on Social Media

Different postconditioning cycles affect prognosis of aged patients undergoing primary percutaneous coronary intervention

Jie Zhang1, Xin Zhang2, Yuqi Cui3, Misbahul Ferdous3, Lianqun Cui3, Peng Zhao3
Pubmed: 28714526
Cardiol J 2018;25(6):666-673.

Abstract

Background: Postconditioning can affect the infarct size in acute myocardial infarction (AMI). How­ever, few studies show an effect of different postconditioning cycles on AMI aged patients. This study sought to assess the effect of different postconditioning cycles on prognosis in aged patients with AMI who underwent primary percutaneous coronary intervention (PCI).

Methods: Seventy four aged patients were randomly assigned to three groups. Control group; PC-1 group accepted postconditioning 4 cycles of 30 s inflation and 30 s deflation; PC-2 group accepted postconditioning 4 cycles of 60 s. Creatine kinase MB (CK-MB), troponin I (cTnI), high-sensitive C-reactive protein (hs-CRP) and corrected Thrombolysis in Myocardial Infarction (TIMI) frame counts (CTFC) were analyzed before and after treatment. All patients received an echocardiographic examina­tion for whole heart function, wall motion score index (WMSI) and single-photon emission computed tomography (SPECT) examination at 7 days and 6 months after treatment.

Results: The peak of CK-MB, postoperative 72 h cTnI and CTFC were significantly attenuated by postconditioning when compared with the control group. The hs-CRP of the postconditioning group was lower than the control group 24 h postoperative. No difference was observed between PC-1 and PC-2 group about the effect described above. At 7 days, heart function in the postconditioning group was im­proved when compared with the control group. At 6 months, the WMSI and SPECT score significantly reduced in the PC-2 group compared with the control and PC-1 groups, but there was no difference among the three groups about echo data except the left ventricular end-systolic diameter.

Conclusions: Postconditioning is significantly beneficial to prognosis in aged patients with AMI. The cardiac protective effect of 4 cycles of 60 s procedure was observed in WMSI and SPECT. It is favorable to implement this procedure in aged patients with AMI in clinic.

Article available in PDF format

View PDF Download PDF file

References

  1. O'Gara PT, Kushner FG, Ascheim DD, et al. American College of Emergency P, Society for Cardiovascular A, Interventions, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013; 61: 485–510.
  2. Chi HJ, Chen ML, Yang XC, et al. Progress in Therapies for Myocardial Ischemia Reperfusion Injury. Curr Drug Targets. 2016 [Epub ahead of print].
  3. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285(2): H579–H588.
  4. Jivraj N, Liew F, Marber M. Ischaemic postconditioning: cardiac protection after the event. Anaesthesia. 2015; 70(5): 598–612.
  5. Hu Xq, Cheng J, Tang B, et al. Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials. J Zhejiang Univ Sci B. 2015; 16(3): 198–207.
  6. Ma XJ, Yin HJ, Guo CY, et al. Ischemic postconditioning through percutaneous transluminal coronary angioplasty in pigs: roles of PI3K activation. Coron Artery Dis. 2012; 23(4): 245–250.
  7. Liu SH, Huo YE, Jia XW, et al. Effects of ischemic postconditioning on expressions of pentraxin-related protein 3 and neutrophil CD11b in the plasma of patients with acute myocardial infarction after percutaneous coronary intervention. Pak J Med Sci. 2016; 32(2): 427–430.
  8. Limalanathan S, Andersen GØ, Kløw NE, et al. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. J Am Heart Assoc. 2014; 3(2): e000679.
  9. Freixa X, Bellera N, Ortiz-Pérez JT, et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J. 2012; 33(1): 103–112.
  10. Zhao P, Zhang J, Yin XG, et al. The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy. Life Sci. 2013; 92(11): 633–638.
  11. Ma X, Zhang X, Li C, et al. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction. J Interv Cardiol. 2006; 19(5): 367–375.
  12. Icli A, Mutlu H, Karabag T, et al. Decreased coronary blood flow velocity in patients with aortic insufficiency but normal coronary arteries: the use of TIMI frame count in aortic insufficiency cases. Int J Clin Exp Med. 2015; 8(9): 16358–16363.
  13. Lebeau R, Sas G, El Rayes M, et al. Left ventricular ejection fraction assessment by non-cardiologists from transverse views using a simplified wall motion score index. Echo Res Pract. 2015; 2(1): 1–8.
  14. Xue F, Yang X, Zhang B, et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol. 2010; 33(7): 439–444.
  15. Lesiak M, Cugowska M, Araszkiewicz A, et al. Impact of the presence of chronically occluded coronary artery on long-term prognosis of patients with acute ST-segment elevation myocardial infarction. Cardiol J. 2017; 24(2): 117–124.
  16. Gao J, Luo J, Liu F, et al. Short-and long-term effects of ischemic postconditioning in STEMI patients: a meta-analysis. Lipids Health Dis. 2015; 14: 147.
  17. Hahn JY, Yu CW, Park HS, et al. Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial. Am Heart J. 2015; 169(5): 639–646.
  18. Sörensson P, Rydén L, Saleh N, et al. Long-term impact of postconditioning on infarct size and left ventricular ejection fraction in patients with ST-elevation myocardial infarction. BMC Cardiovasc Disord. 2013; 13: 22.
  19. Zhou C, Yao Y, Zheng Z, et al. Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials. Eur Heart J. 2012; 33(24): 3070–3077.
  20. Araszkiewicz A, Grygier M, Pyda M, et al. Postconditioning reduces enzymatic infarct size and improves microvascular reperfusion in patients with ST-segment elevation myocardial infarction. Cardiology. 2014; 129(4): 250–257.
  21. Tong G, Aponte AM, Kohr MJ, et al. Postconditioning leads to an increase in protein S-nitrosylation. Am J Physiol Heart Circ Physiol. 2014; 306(6): H825–H832.
  22. Liu ZZ, Kong JB, Li FZ, et al. Ischemic postconditioning decreases matrix metalloproteinase-2 expression during ischemia-reperfusion of myocardium in a rabbit model: A preliminary report. Exp Clin Cardiol. 2013; 18(2): e99–e9e101.
  23. He H, Li N, Zhao Z, et al. Ischemic postconditioning improves the expression of cellular membrane connexin 43 and attenuates the reperfusion injury in rat acute myocardial infarction. Biomed Rep. 2015; 3(5): 668–674.
  24. Kin H, Zhao ZQ, Sun HY, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004; 62(1): 74–85.
  25. Lin XM, Zhang ZY, Wang LF, et al. Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J (Engl). 2010; 123(14): 1833–1839.